Navigation Links
Dyadic International Reports First Quarter 2013 Financial Results
Date:5/15/2013

nse on Stock Option Grants 193,776308,974 Changes in Operating Assets and Liabilities:  Accounts Receivable (141,804)127,574 License Fee Receivable 1,000,000- Inventory 658,266(507,903) Prepaid Expenses and Other Current Assets (5,054)(76,398) Accounts Payable (310,552)114,106 Accrued Expenses (28,142)(11,410) Accrued Interest Payable 168,928(131) Deferred Research and Development Obligation (74,231)307,275 Net Cash Provided By (Used In) Operating Activities 153,805(454,183) Investing Activities  Purchases of Fixed Assets (88,168)(6,332) Cost of Patents (8,060)(17,099) Restricted Cash 5,801(7,496) Net Cash (Used In) Investing Activities (90,427)(30,927) Financing Activities  Proceeds from Stock Option Exercises 58,50023,337 Net Increase (Decrease) in Cash and Cash Equivalents 121,878(461,773) Cash and Cash Equivalents at Beginning of Period 3,990,0623,691,755 Cash and Cash Equivalents at End of Period 

$

4,111,940$

3,229,982 Supplemental Cash Flow Information:  Cash Paid for Interest 

$

-$

173,496 Non-Cash Items:  Conversion of Convertible Subordinated Debtinto Shares of Common Stock 

$

182,000$

-
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
2. Danai Brooks Joins Dyadic International as Chief Operating Officer
3. Dyadic International To Speak At Advanced Biofuels Leadership Conference Panel Discussion
4. Dyadic International To Present At World Biofuels Markets
5. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
6. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
7. 12th U.S. Patent Issued To Dyadic International
8. Dyadic International Reports 2012 Third Quarter Financial Results
9. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
10. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
11. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... and MENLO PARK, Calif. ... (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical ... in new orphan drug indications, today announced that the ... as a clinical trial site for the ongoing, multicenter ... glioblastoma multiforme (GBM), the most common and deadly form ...
(Date:4/16/2015)... BETHESDA, Md. , April 16, 2015 /PRNewswire/ ... Bio"), a biotechnology company developing non-toxic DCVax® personalized ... has been included in the Loncar Cancer Immunotherapy ... help investors better track the immunotherapy field within ... founders have selected "the top 25 companies" in ...
(Date:4/16/2015)... Modality Solutions, a company that delivers ... industries, is pleased to announce its President, Gary ... Cold Chain IQ - Temperature Control Logistics and ... Global Cold Chain Connections, is dedicated to sharing ... pharmaceutical and healthcare supply chains. , Cold ...
(Date:4/15/2015)... England , April 16, 2015 ... developing novel biological drugs to treat cancer and ... and development arm of AstraZeneca, today announced that ... Under the terms of the agreement, Immunocore ... MedImmune,s investigational checkpoint inhibitors MEDI4736 (anti-PD-L1) and/or tremelimumab ...
Breaking Biology Technology:DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 2NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 3Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 2Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 3Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 2Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 3Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 4Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 5Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma 6
... antibody isotyping in only 5 minutes , ... Holmes Peter L.,Pingerelli ,Stratagene Cloning Systems, Inc. ... is a,simple, rapid and sensitive method for identifying ... IsoDetect test card is a self-contained assay,using colloidal ...
... pathways , , Li Xu Tim ... Enhancer elements are the convergent points for many ... assessment of the in,vivo activation of these pathways, ... signal transduction pathway cis-reporting systems. Each of the ...
... with high-titer efficiency and larger insert,potential ... Expression Libraries , Katherine Felts Kim ... Waesche Peter Vaillancourt ,Stratagene , We ... libraries inserted into the,high-titer retroviral vector pFB. ...
Cached Biology Technology:Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 2Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 3Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 4Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 5Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 2Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 3Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 4Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 2Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 3Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 4Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 5Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 6Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 7Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 8Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 9Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 10Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 11
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... wallet is one of the products featured in 2015 ... 20th at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the ...
(Date:3/19/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces its biometric payment technology, the ... aired this week on Washington DC,s ... a segment "The Next Great Thing", host Laura Evans ... pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
Breaking Biology News(10 mins):NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... September) by the Biotechnology and Biological Sciences Research Council ... of photosynthesis the process by which plants harvest ... major increases in crop yields for food, bioenergy and ... has been provided for these projects which complement four ...
... DigitalPersona, Inc. , a global provider of authentication and ... fingerprint biometric Civil ID solutions at this ... Supported by the National Institute of Standards and Technology ... Consortium Conference is focused on biometric technologies for Defense, ...
... by LSU Associate Professors of Biological Sciences Fernando Galvez and ... and laboratory study showing the effects of the Deepwater Horizon ... , The study, funded in part by the National Science ... is being published in the journal Proceedings of the ...
Cached Biology News:Research to improve photosynthesis for increased food and fuel production 2DigitalPersona Showcases Fingerprint Biometrics for Civil ID Applications at the Biometric Consortium Conference 2DigitalPersona Showcases Fingerprint Biometrics for Civil ID Applications at the Biometric Consortium Conference 3LSU researchers find impact of oil spill in marsh fish species 2
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... designer enzyme that enables RT-PCR in ... enzyme allows reverse transcription and PCR ... temperatures (65C), which helps to remove ... results in highly stringent, accurate annealing ...
... Mch3 Lyophilized solid. ... regulation and kinetics, cleavage of target substrates, and inhibitor ... One unit is defined as the amount ... Cat. No. 235400 per hour at 37 C at ...
Biology Products: